Effectiveness of Periodontal Treatment for the Glycemic Conttrol of Type II Diabetes Mellitus
NCT ID: NCT05587413
Last Updated: 2022-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
112 participants
INTERVENTIONAL
2022-11-02
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periodontal Health and Its Impact on Oral Health-related Quality of Life Among Diabetes Mellitus Patients
NCT06125561
Periodontal Treatment and Glycemic Control
NCT01901926
Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy
NCT03343366
Clinical Efficacy of 1% Metformin and Alendronate Gel in Adjunct to Fibrin in Chronic Periodontitis
NCT06856369
Type I Diabetes and Non-surgical Periodontal Treatment
NCT05569525
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment group
periodontal care
periodontal treatment
control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
periodontal care
periodontal treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged between 30-60 years.
3. Patients with HbA1C level 7-9.5%, measured within three months prior to present study.
Exclusion Criteria
2. Need for immediate tooth extractions
3. Severe Hypertension (\>180/110 mm Hg)
4. Edentulous Patients
5. Patients with Diabetic Nephropathy
6. Patients with Diabetic Retinopathy
30 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lahore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gul Muhammad Shaikh
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uol
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
gul
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UIPH/UOL/193/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.